Liu Tianyu, Ding Quchen, Gou Jin, Lu Chen, Lu Xingming, Chen Jiatong, E Yiming, Li Lianhong, Zhang Chongguo, Zhu Xiaojuan, Yu Chunzhao, Luo Xiagang
Department of General Surgery, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Front Immunol. 2025 Oct 31;16:1682637. doi: 10.3389/fimmu.2025.1682637. eCollection 2025.
FAM49B has been shown to promote proliferation and metastasis of colorectal cancer (CRC) by stabilizing MYC through phosphorylation of NEK9; however, its role in shaping the immune suppressive tumor microenvironment (TME), particularly in macrophage polarization, remains unclear.
We applied multi-omics approaches to study CRC by integrating 33 scRNA-seq samples from 16 CRC patients, 2 paired spatial transcriptomics (ST) samples, and bulk RNA data to characterize malignant epithelial cells (High_FAM49B_EP) and tumor-associated macrophages (TAMs). Functional validation of FAM49B was conducted via knockdown experiments and proteomics analysis.
A High_FAM49B_EP subpopulation was identified in primary tumors (PT) and liver metastases (LM), exhibiting elevated MYC signaling and association with poor prognosis. TAMs showed spatial heterogeneity: M1-like CXCL3 TAMs predominated in PT, whereas M2-like SPP1 TAMs were enriched in LM. CellChat analysis revealed that High_FAM49B_EP activated macrophage polarization through the MDK-NCL signaling axis. Pseudotime trajectory analysis confirmed differentiation from CXCL3 to SPP1 TAMs driven by upregulation of NCL. Spatial mapping showed co-localization of MDK epithelial cells with NCL TAMs in the immunosuppressive microenvironment. FAM49B knockdown significantly inhibited MDK expression and disrupted ECM-receptor interactions.
FAM49B promotes immunosuppressive TME formation by mediating TAM polarization via the MDK-NCL axis, suggesting the FAM49B-MDK-NCL pathway as a potential therapeutic target for CRC metastasis.
FAM49B已被证明可通过对NEK9进行磷酸化来稳定MYC,从而促进结直肠癌(CRC)的增殖和转移;然而,其在塑造免疫抑制性肿瘤微环境(TME),特别是在巨噬细胞极化中的作用仍不清楚。
我们应用多组学方法,通过整合来自16例CRC患者的33个单细胞RNA测序(scRNA-seq)样本、2对空间转录组学(ST)样本和批量RNA数据,来表征恶性上皮细胞(High_FAM49B_EP)和肿瘤相关巨噬细胞(TAM)。通过敲低实验和蛋白质组学分析对FAM49B进行功能验证。
在原发性肿瘤(PT)和肝转移灶(LM)中鉴定出一个High_FAM49B_EP亚群,其MYC信号升高且与预后不良相关。TAM表现出空间异质性:M1样CXCL3 TAM在PT中占主导,而M2样SPP1 TAM在LM中富集。CellChat分析显示,High_FAM49B_EP通过MDK-NCL信号轴激活巨噬细胞极化。伪时间轨迹分析证实,由NCL上调驱动从CXCL3 TAM向SPP1 TAM分化。空间映射显示,在免疫抑制微环境中,MDK上皮细胞与NCL TAM共定位。FAM49B敲低显著抑制MDK表达并破坏细胞外基质-受体相互作用。
FAM49B通过MDK-NCL轴介导TAM极化促进免疫抑制性TME形成,提示FAM49B-MDK-NCL通路可能是CRC转移的治疗靶点。